Vaishali Pharma discloses under SEBI 31(4) that promoters and promoter group did not encumber shares during FY ended 31 March 2026, confirming regulatory compliance and transparency.
AI Assistant
Vaishali Pharma Ltd
2026
Announcement
Find Answers
Ask about any part of the document to get insights, explanations, or key details.